Aeolus Pharmaceuticals, Inc.
AOLS
$0.0001
$0.000.00%
OTC PK
| 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | 06/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -4.09M | -4.02M | -3.61M | -3.56M | -2.97M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 12.00K | 12.00K | 12.00K | 285.00K | 273.00K |
| Total Other Non-Cash Items | 104.00K | 109.00K | 118.00K | 141.00K | 0.00 |
| Change in Net Operating Assets | 625.00K | 369.00K | -67.00K | 23.00K | -1.13M |
| Cash from Operations | -3.35M | -3.53M | -3.55M | -3.11M | -3.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 1.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 2.01M | 2.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 335.00K | 335.00K | 335.00K | 4.50M | 4.17M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -335.00K | -335.00K | -335.00K | -335.00K | -- |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 6.17M | 7.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.35M | -3.53M | -3.55M | 3.06M | 3.34M |